Globus Medical Releases New ALIF Device

Globus Medical Inc. has launched Monument, an anterior lumbar interbody fusion (ALIF) device with a built-in mechanical feature designed to aid in spondylolisthesis reduction. Spondylolisthesis is a condition in which a bone in the spine slips out of the proper position onto the bone below it.

The company’s 510(k) application was cleared by the U.S. Food and Drug Administration in late December last year.

The self-locking and threaded translational feature can be engaged to reduce the implant up to 8 millimeters in situ and the screws are designed for optimal cortical purchase

“Monument, with its threaded translational reduction feature, is designed to be more efficient for the surgeon by incorporating mechanized implant reduction with an integrated plate-spacer. Alternative procedures require additional steps in treating this challenging condition. Our new system includes all the benefits typical of an anterior lumbar interbody spacer with a large stabilizing surface area and large graft window to optimize fusion,” said Andrew Iott, senior vice president of product development for Audubon, Pa.-based Globus.

“The implant’s translational reduction feature performs exceptionally well. Monument offers the benefits of an integrated ALIF system and simple, intuitive instruments combined with in-situ implant reduction, making it an attractive surgical solution for patients with spondylolisthesis,” said Christopher Tomaras, M.D., neurosurgeon at Peachtree Neurosurgery in Atlanta, Ga.

The Monument spacer is available in different sizes, heights and sagittal angles to accommodate the lumbar and sacral spine, including L5-S1. The device is intended for use with supplemental fixation.

Globus Medical is a musculoskeletal implant company primarily engaged in spine procedures.